Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
AbstractBackground. O6-methylguanine DNA-methyl transferase (MGMT) promoter methylation status is predictive for alkylating chemotherapy, but there are non-bene
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
17 February 2020
|
| In: |
Neuro-Oncology
Year: 2020, Jahrgang: 22, Heft: 8, Pages: 1162-1172 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noaa033 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noaa033 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/22/8/1162/5737806 |
| Verfasserangaben: | Antje Wick, Tobias Kessler, Michael Platten, Christoph Meisner, Michael Bamberg, Ulrich Herrlinger, Jörg Felsberg, Astrid Weyerbrock, Kirsten Papsdorf, Joachim P. Steinbach, Michael Sabel, Jan Vesper, Jürgen Debus, Jürgen Meixensberger, Ralf Ketter, Caroline Hertler, Regine Mayer-Steinacker, Sarah Weisang, Hanna Bölting, David Reuss, Guido Reifenberger Felix Sahm, Andreas von Deimling, Michael Weller, and Wolfgang Wick, |
| Zusammenfassung: | AbstractBackground. O6-methylguanine DNA-methyl transferase (MGMT) promoter methylation status is predictive for alkylating chemotherapy, but there are non-bene |
|---|---|
| Beschreibung: | Gesehen am 21.01.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noaa033 |